Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent Deferred RevenueInventoryLiabilities and Shareholders EquityNon-Current DebtOther Non-Current LiabilitiesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Goldenwell Biotech (GWLL) Inventory (2021 - 2025)

Goldenwell Biotech (GWLL) has disclosed Inventory for 5 consecutive years, with $174788.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Inventory changed 0.06% year-over-year to $174788.0, compared with a TTM value of $174788.0 through Sep 2025, changed 0.06%, and an annual FY2024 reading of $174788.0, changed 0.04% over the prior year.
  • Inventory was $174788.0 for Q3 2025 at Goldenwell Biotech, roughly flat from $174788.0 in the prior quarter.
  • Across five years, Inventory topped out at $205725.0 in Q2 2021 and bottomed at $103125.0 in Q1 2021.
  • Average Inventory over 5 years is $177842.1, with a median of $175013.0 recorded in 2023.
  • Peak annual rise in Inventory hit 92.47% in 2022, while the deepest fall reached 12.18% in 2022.
  • Year by year, Inventory stood at $198671.0 in 2021, then decreased by 11.38% to $176058.0 in 2022, then fell by 0.68% to $174863.0 in 2023, then decreased by 0.04% to $174788.0 in 2024, then changed by 0.0% to $174788.0 in 2025.
  • Business Quant data shows Inventory for GWLL at $174788.0 in Q3 2025, $174788.0 in Q2 2025, and $174788.0 in Q1 2025.